Astigmatism Market Size, Trends And Forecast To 2034

Market Overview:

The astigmatism market reached a value of US$ 1.3 Billion in 2023 and expected to reach US$ 1.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.49% during 2024-2034.

The report offers a comprehensive analysis of the astigmatism market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the astigmatism market.

Request for a Sample of this Report: https://www.imarcgroup.com/astigmatism-market/requestsample

What Are the Growth Prospects and Trends in Astigmatism Market?

Astigmatism refers to a prevalent eye disorder that alters how light enters the eye, leading to blurry or skewed vision. The issue stems from an abnormal curvature of the eye's cornea or lens, resulting in light rays converging on several points rather than one on the retina. Symptoms can include eye strain, fatigue, distorted or inclined vision, discomfort, headaches, squinting, and challenges with night vision and focus. Ophthalmologists diagnose astigmatism through a comprehensive patient history review, clinical signs assessment, and precise eye tests. They use a device called a phoropter to evaluate the extent of the refractive error. To get an in-depth corneal map that reveals any irregularities, they may also employ corneal topography. Other tools like visual acuity tests, keratometry, and retinoscopy could be applied to solidify the diagnosis and exclude other potential conditions.

The astigmatism market is seeing a surge, primarily fueled by increasing eye trauma cases, such as penetrating injuries that modify corneal or lens shape. The market is also stimulated by genetic factors, leading to gene variations impacting the formation of the cornea, lens, and other eye components. Additionally, the widespread utilization of orthokeratology, a technique using special gas-permeable contact lenses worn overnight to restructure the cornea and correct astigmatism, is another significant factor driving the market growth. The growing implementation of vision therapy, a regimen of exercises and methods aimed at enhancing visual abilities and reducing disease symptoms, also bolsters the market. Moreover, the rising demand for the LASIK procedure, known for its several benefits like swift vision correction and improved patient quality of life, is anticipated to boost the astigmatism market further in the future.

Countries Covered:

• United States

• Germany

• France

• United Kingdom

• Italy

• Spain

• Japan

Analysis Covered Across Each Country:

• Historical, current, and future epidemiology scenario

• Historical, current, and future performance of the astigmatism market

• Historical, current, and future performance of various therapeutic categories in the market

• Sales of various drugs across the astigmatism market

• Reimbursement scenario in the market

• In-market and pipeline drugs

This report also provides a detailed analysis of the current astigmatism marketed drugs and late-stage pipeline drugs.

In-Market Drugs:

• Drug Overview

• Mechanism of Action

• Regulatory Status

• Clinical Trial Results

• Drug Uptake and Market Performance

Late-Stage Pipeline Drugs:

• Drug overview

• Mechanism of action

• Regulatory status

• Clinical trial results

• Drug uptake and market performance

Competitive Landscape:

The competitive landscape of the astigmatism market has been studied in the report with the detailed profiles of the key players operating in the market.

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=7945&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163